Analysis-GSK Gives Few Clues On Plans To Replenish Medicine Cabinet
By Natalie Grover and Maggie Fick LONDON (Reuters) – GSK chief executive Emma Walmsley on Wednesday made replenishing the drugmaker’s pipeline of vaccines and therapies her number-one priority. But analysts were disappointed she did not give more details on how she and her management team plan to find the company’s next set of blockbuster drugs….